霍奇金淋巴瘤胸部放疗后乳腺癌的遗传易感性
该研究在327例霍奇金淋巴瘤胸部放疗后乳腺癌患者和4671例首发原发性乳腺癌患者中进行病例-only分析,发现9个SNP与放疗交互影响乳腺癌风险,其中PVT1基因1个SNP达Bonferroni显著阈值;在327例放疗后乳腺癌与491例放疗后无乳腺癌患者的病例对照分析中,RT交互PRS最高三分位较低三分位乳腺癌风险高1.6倍,BC-PRS最高十分位较低十分位风险高4倍。
要点
- 9个SNP与胸部放疗交互影响霍奇金淋巴瘤后乳腺癌风险,PVT1基因1个SNP达Bonferroni阈值。
- RT交互PRS最高三分位者乳腺癌风险为最低三分位的1.6倍。
- BC-PRS最高十分位者放疗诱发乳腺癌风险为最低十分位的4倍。
核心结论
- 遗传因素影响霍奇金淋巴瘤胸部放疗后乳腺癌风险。
- 鉴于放疗暴露女性乳腺癌绝对风险高,这些结果对当前霍奇金淋巴瘤生存者和未来患者的管理可能有重要启示。
研究设计与样本
- 病例-only分析纳入327例霍奇金淋巴瘤胸部放疗后乳腺癌患者和4671例首发原发性乳腺癌患者,检测211155个胚系SNP的基因-放疗交互作用。
- 病例对照分析纳入327例胸部放疗后乳腺癌的霍奇金淋巴瘤患者和491例胸部放疗后无乳腺癌的霍奇金淋巴瘤患者,评估RT交互PRS和BC-PRS。
主要发现
- 9个SNP与放疗对乳腺癌风险存在统计学显著交互作用(错误发现率<20%),其中PVT1癌基因中1个SNP达到Bonferroni统计显著性阈值。
- RT交互PRS最高三分位患者乳腺癌风险为最低三分位的1.6倍。
- BC-PRS最高十分位患者放疗诱发乳腺癌风险为最低十分位的4倍。
- 连续尺度上,BC-PRS每增加1个标准差乳腺癌风险增加1.4倍,与普通人群中效应量相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Female Hodgkin lymphoma (HL) patients treated with chest radiotherapy (RT) have a very high risk of breast cancer. The contribution of genetic factors to this risk is unclear. We therefore examined 211 155 germline single-nucleotide polymorphisms (SNPs) for gene-radiation interaction on breast cancer risk in a case-only analysis including 327 breast cancer patients after chest RT for HL and 4671 first primary breast cancer patients. Nine SNPs showed statistically significant interaction with RT on breast cancer risk (false discovery rate, <20%), of which 1 SNP in the PVT1 oncogene attained the Bonferroni threshold for statistical significance. A polygenic risk score (PRS) composed of these SNPs (RT-interaction-PRS) and a previously published breast cancer PRS (BC-PRS) derived in the general population were evaluated in a case-control analysis comprising the 327 chest-irradiated HL patients with breast cancer and 491 chest-irradiated HL patients without breast cancer. Patients in the highest tertile of the RT-interaction-PRS had a 1.6-fold higher breast cancer risk than those in the lowest tertile. Remarkably, we observed a fourfold increased RT-induced breast cancer risk in the highest compared with the lowest decile of the BC-PRS. On a continuous scale, breast cancer risk increased 1.4-fold per standard deviation of the BC-PRS, similar to the effect size found in the general population. This study demonstrates that genetic factors influence breast cancer risk after chest RT for HL. Given the high absolute breast cancer risk in radiation-exposed women, these results can have important implications for the management of current HL survivors and future patients.
引用
- Opstal-van Winden AWJ, de Haan HG, Hauptmann M, et al. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood. 2018. PMID: 30573632. doi:10.1182/blood-2018-07-862607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。